Literature DB >> 12742097

Glutamine transport in C6 glioma cells shows ASCT2 system characteristics.

Monika Dolińska1, Anna Dybel, Barbara Zabłocka, Jan Albrecht.   

Abstract

Previous studies from this laboratory have shown that glutamine (Gln) uptake in a rat astrocytoma-derived C6 cell line shows characteristics similar with the uptake of a model ASC system substrate, threonine, whose pH-dependence and partial tolerance of Li(+) substitution for Na(+) resemble the ASCT2 variant of the system. In support of the previous findings, RT-PCR analysis revealed that C6 cells strongly express ASCT2 mRNA, but not at all GlnT mRNA or NAT2 mRNA, the A and N system variants specifically engaged in Gln transport in normal CNS. Other features of Gln transport in C6 cells indicating the involvement of ASCT2 system included its resistance to ouabain and stimulation of Gln efflux from the cells in the presence of excess Gln or cysteine (Cys), demonstrating that the system operates in the exchange mode. Replacement of NaCl in the incubation medium with isoosmotic sucrose did neither significantly affect the kinetics, nor any other major characteristics of Gln or Thr transport, including its pH-dependence, inhibition by ASCT system substrates or resistance to the model system A substrate-N-methylamino-isobutyric acid (MeAiB).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742097     DOI: 10.1016/s0197-0186(03)00040-8

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  11 in total

1.  Oxidative stress increases SNAT1 expression and stimulates cysteine uptake in freshly isolated rat cardiomyocytes.

Authors:  Nicola King; Hua Lin; M-Saadeh Suleiman
Journal:  Amino Acids       Date:  2010-07-03       Impact factor: 3.520

2.  Manganese disrupts astrocyte glutamine transporter expression and function.

Authors:  Marta Sidoryk-Wegrzynowicz; Eunsook Lee; Jan Albrecht; Michael Aschner
Journal:  J Neurochem       Date:  2009-05-15       Impact factor: 5.372

Review 3.  Glutamine Addiction In Gliomas.

Authors:  Javier Márquez; Francisco J Alonso; José M Matés; Juan A Segura; Mercedes Martín-Rufián; José A Campos-Sandoval
Journal:  Neurochem Res       Date:  2017-03-09       Impact factor: 3.996

4.  Towards improved boron neutron capture therapy agents: evaluation of in vitro cellular uptake of a glutamine-functionalized carborane.

Authors:  Antonella Crivello; Carlo Nervi; Roberto Gobetto; Simonetta Geninatti Crich; Iboya Szabo; Alessandro Barge; Antonio Toppino; Annamaria Deagostino; Paolo Venturello; Silvio Aime
Journal:  J Biol Inorg Chem       Date:  2009-04-10       Impact factor: 3.358

Review 5.  Sodium homeostasis in the tumour microenvironment.

Authors:  Theresa K Leslie; Andrew D James; Fulvio Zaccagna; James T Grist; Surrin Deen; Aneurin Kennerley; Frank Riemer; Joshua D Kaggie; Ferdia A Gallagher; Fiona J Gilbert; William J Brackenbury
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-07-23       Impact factor: 10.680

Review 6.  Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.

Authors:  Lian Chen; Hengmin Cui
Journal:  Int J Mol Sci       Date:  2015-09-22       Impact factor: 5.923

Review 7.  Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.

Authors:  Lorena Pochini; Mariafrancesca Scalise; Michele Galluccio; Cesare Indiveri
Journal:  Front Chem       Date:  2014-08-11       Impact factor: 5.221

8.  Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5.

Authors:  Amanda J Scopelliti; Josep Font; Robert J Vandenberg; Olga Boudker; Renae M Ryan
Journal:  Nat Commun       Date:  2018-01-02       Impact factor: 14.919

Review 9.  Involvement of tumor acidification in brain cancer pathophysiology.

Authors:  Avinash Honasoge; Harald Sontheimer
Journal:  Front Physiol       Date:  2013-11-01       Impact factor: 4.566

Review 10.  Targeting Glutamine Addiction in Gliomas.

Authors:  Marta Obara-Michlewska; Monika Szeliga
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.